Literature DB >> 22974763

The nitroxide TEMPO is an efficient scavenger of protein radicals: cellular and kinetic studies.

David I Pattison1, Magdalena Lam, Sujata S Shinde, Robert F Anderson, Michael J Davies.   

Abstract

Protein oxidation occurs during multiple human pathologies, and protein radicals are known to induce damage to other cell components. Such damage may be modulated by agents that scavenge protein radicals. In this study, the potential protective reactions of the nitroxide TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxyl radical) against Tyr- and Trp-derived radicals (TyrO./TrpN.) have been investigated. Pretreatment of macrophage cells with TEMPO provided protection against photo-oxidation-induced loss of cell viability and Tyr oxidation, with the nitroxide more effective than the hydroxylamine or parent amine. Pulse radiolysis was employed to determine rate constants, k, for the reaction of TEMPO with TyrO. and TrpN. generated on N-Ac-Tyr-amide and N-Ac-Trp-amide, with values of k~10(8) and 7×10(6)M(-1)s(-1), respectively, determined. Analogous studies with lysozyme, chymotrypsin, and pepsin yielded k for TEMPO reacting with TrpN. ranging from 1.5×10(7) (lysozyme) to 1.1×10(8) (pepsin)M(-1)s(-1). Pepsin-derived TyrO. reacted with TEMPO with k~4×10(7)M(-1)s(-1); analogous reactions for lysozyme and chymotrypsin TyrO. were much slower. These data indicate that TEMPO can inhibit secondary reactions of both TyrO. and TrpN., though this is protein dependent. Such protein radical scavenging may contribute to the positive biological effects of nitroxides.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974763     DOI: 10.1016/j.freeradbiomed.2012.08.578

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

1.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

2.  [Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin].

Authors:  Shuangyan Ye; Sisi Zeng; Mengqiu Huang; Jianping Chen; Xi Chen; Pengfei Xu; Qianli Wang; Wenwen Gao; Bingsheng Yang; Bingtao Hao; Wenhuan Huang; Qiuzhen Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

3.  Reactive oxygen species and c-Jun N-terminal kinases contribute to TEMPO-induced apoptosis in L5178Y cells.

Authors:  Xiaoqing Guo; Si Chen; Zhuhong Zhang; Vasily N Dobrovolsky; Stacey L Dial; Lei Guo; Nan Mei
Journal:  Chem Biol Interact       Date:  2015-04-13       Impact factor: 5.192

4.  It takes two for chronic wounds to heal: dispersing bacterial biofilm and modulating inflammation with dual action plasma coatings.

Authors:  Thomas Danny Michl; Dung Thuy Thi Tran; Hannah Frederike Kuckling; Aigerim Zhalgasbaikyzy; Barbora Ivanovská; Laura Elena González García; Rahul Madathiparambil Visalakshan; Krasimir Vasilev
Journal:  RSC Adv       Date:  2020-02-18       Impact factor: 4.036

5.  The Effect of Covalently-Attached ATRP-Synthesized Polymers on Membrane Stability and Cytoprotection in Human Erythrocytes.

Authors:  William P Clafshenkel; Hironobu Murata; Jill Andersen; Yehuda Creeger; Richard R Koepsel; Alan J Russell
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

6.  The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism.

Authors:  Shuangyan Ye; Pengfei Xu; Mengqiu Huang; Xi Chen; Sisi Zeng; Qianli Wang; Jianping Chen; Keyi Li; Wenwen Gao; Ruiyuan Liu; Jingxian Liu; Yihao Shao; Hui Zhang; Yang Xu; Qianbing Zhang; Zhuo Zhong; Zibo Wei; Jiale Wang; Bingtao Hao; Wenhua Huang; Qiuzhen Liu
Journal:  Cell Death Dis       Date:  2020-05-04       Impact factor: 9.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.